Does Votrient cure cancer or shrink tumors?
Votrient is not a cure for cancer, but it does increase progression-free survival – this is the length of time during and after treatment that a patient lives with the disease but it does not get worse – and can shrink or slow the growth of kidney cancer in some people. Effects are more pronounced in previously untreated patients.
- Progression-free survival was, on average, 9.2 months with Votrient compared with 4.2 months among patients given a placebo (an inactive treatment) in a trial that involved 435 patients with locally advanced or metastatic RCC
- Progression-free survival among previously untreated patients was 11.1 months with Votrient compared with 2.8 months among patients given a placebo
- Among previously treated patients, progression-free survival was 7.4 months among patients treated with Votrient and 4.2 months among patients given a placebo
- The most common side effects of Votrient were diarrhea (52%), high blood pressure (40%), hair color changes (38%), nausea (26%), weight loss (22%), and vomiting (21%)
- A preliminary study in children and adults with advanced soft tissue sarcoma showed that adding Votrient to chemotherapy and radiation treatment was safe and increased the chances that most of the tumor was dead before surgery.
Votrient is an oral tablet that is taken once daily to treat adults with soft tissue sarcoma who have received prior chemotherapy or advanced renal cell carcinoma.
References
- Votrient (pazopanib hydrochloride) Updated 08/2020 Novartis Pharmaceuticals Corporation. https://www.drugs.com/pro/votrient.html
- Pazopanib Shows Promise for Children, Adults with Soft Tissue Sarcomas National Cancer Institute. Sept 9 2020. https://www.cancer.gov/news-events/cancer-currents-blog/2020/pazopanib-votrient-soft-tissue-sarcoma-children-adults
Read next
Related medical questions
- What is the strongest chemotherapy drug for breast cancer?
- Is small cell or non-small cell lung cancer worse?
- Is non-small cell lung cancer hereditary?
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of prostate cancer is Erleada used to treat?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
- Oxycodone vs Hydrocodone - How do they compare?
- Does omeprazole cause cancer?
- Why is Xanax so addictive?
- How do you increase platelet count during chemotherapy?
- What are monoclonal antibodies?
- Vicodin vs Percocet: What's the difference?
- How do I know if immunotherapy is working?
- Why give Taxol (Paxel) before carboplatin?
- What is Quercetin and what are its health benefits?
- What are anti-VEGF drugs (VEGF inhibitors)?
- What’s the mechanism of action of Carvykti?
- My stool has changed color. What does it mean?
- How do I know if Aldara is working for skin cancer?
- How does Ibrance kill cancer?
- Does Xolair cause cancer?
- Does Skyrizi cause cancer?
- Can Tymlos cause bone cancer?
- Is food coloring bad for you?
- How much does Tecartus cost?
- How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?
- What is a chemotherapy regimen?
Drug information
Related support groups
- Votrient (5 questions, 88 members)
- Pazopanib (4 questions, 18 members)
- Cancer (176 questions, 637 members)
- Renal Cell Carcinoma (29 questions, 102 members)
- Soft Tissue Sarcoma (6 questions, 14 members)